We are live on ! Find out more
DFO

Duquesne Family Office Portfolio holdings

AUM $3.38B
1-Year Est. Return 61.92%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$2.02B
AUM Growth
+$257M
Cap. Flow
+$168M
Cap. Flow %
8.3%
Top 10 Hldgs %
68.68%
Holding
81
New
16
Increased
11
Reduced
10
Closed
23

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$89.6M
2
META icon
Meta Platforms (Facebook)
META
+$87M
3
NVDA icon
NVIDIA
NVDA
+$85.5M
4
LW icon
Lamb Weston
LW
+$60.5M
5
CVX icon
Chevron
CVX
+$51.2M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$102M
2
MSFT icon
Microsoft
MSFT
+$45.1M
3
TMUS icon
T-Mobile US
TMUS
+$38M
4
WDAY icon
Workday
WDAY
+$36.7M
5
DDOG icon
Datadog
DDOG
+$35.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.51%
2 Consumer Discretionary 17.57%
3 Energy 16.83%
4 Industrials 12.66%
5 Communication Services 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCJ icon
26
Cameco
CCJ
$42.4B
$17M 0.84%
+748,204
New +$17.6M
PXD
27
DELISTED
Pioneer Natural Resource Co.
PXD
$16.3M 0.81%
71,505
-20,025
-22% -$4.87M
CAT icon
28
Caterpillar
CAT
$387B
$15.3M 0.76%
+63,800
New +$13.9M
PANW icon
29
Palo Alto Networks
PANW
$297B
$15.2M 0.75%
218,540
-91,156
-29% -$7.32M
WSC icon
30
WillScot Mobile Mini Holdings
WSC
$4.41B
$14M 0.69%
309,866
-667,765
-68% -$30M
PSX icon
31
Phillips 66
PSX
$81.4B
$11.8M 0.59%
+113,850
New +$11.6M
LVS icon
32
CALL
Las Vegas Sands
LVS
$29.6B
$11.1M 0.55%
230,000
RXRX icon
33
Recursion Pharmaceuticals
RXRX
$1.73B
$10.7M 0.53%
1,385,950
DHI icon
34
D.R. Horton
DHI
$42.3B
$10.1M 0.5%
+113,400
New +$9.09M
IOT icon
35
Samsara
IOT
$23.8B
$10.1M 0.5%
+810,713
New +$9.23M
PLTR icon
36
Palantir
PLTR
$413B
$8.16M 0.4%
1,270,707
-1,150,575
-48% -$8.72M
NEE icon
37
NextEra Energy
NEE
$177B
$7.81M 0.39%
93,400
CEG icon
38
Constellation Energy
CEG
$95.6B
$7.66M 0.38%
88,825
ABCL icon
39
AbCellera Biologics
ABCL
$2.12B
$6.68M 0.33%
659,750
ENVX icon
40
Enovix
ENVX
$1.03B
$5.78M 0.29%
530,743
AMR icon
41
Alpha Metallurgical Resources
AMR
$1.93B
$5.76M 0.29%
39,370
-97,350
-71% -$15.4M
LGIH icon
42
LGI Homes
LGIH
$1.4B
$4.63M 0.23%
+50,000
New +$4.57M
AVTR icon
43
Avantor
AVTR
$9.19B
$4M 0.2%
189,695
MRNA icon
44
Moderna
MRNA
$23.6B
$3.98M 0.2%
22,154
IHS icon
45
IHS Holding
IHS
$2.81B
$3.79M 0.19%
771,096
ENTG icon
46
Entegris
ENTG
$23.2B
$3.64M 0.18%
+55,500
New +$4.09M
RUN icon
47
Sunrun
RUN
$2.46B
$3.34M 0.17%
139,000
CCC
48
CCC Intelligent Solutions
CCC
$4.08B
$2.45M 0.12%
281,879
OSCR icon
49
Oscar Health
OSCR
$8.61B
$2.45M 0.12%
994,289
RETA
50
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.24M 0.11%
58,997

Similar funds

Duquesne Family Office's Q4 2022 Portfolio in Review

As of Q4 2022, Duquesne Family Office held 81 positions worth $2.02B, up 15% from $1.76B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Duquesne Family Office deployed $168M of net new capital in Q4 2022, opening 16 new positions and adding to 11 existing holdings. Its largest new stake was NVIDIA: 5,829,150 shares worth $85.2M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was T-Mobile US, an estimated $38M trimmed.

  • Duquesne Family Office's largest Q4 2022 buy was NVIDIA: 5,829,150 shares worth $85.2M.
  • Duquesne Family Office added most to Eli Lilly in Q4 2022, an estimated $89.6M increase.
  • Duquesne Family Office's biggest Q4 2022 reduction was T-Mobile US, cutting an estimated $38M.
  • Duquesne Family Office fully exited Amazon in Q4 2022, selling an estimated $102M.
  • Duquesne Family Office's ten largest holdings make up 69% of its $2.02B portfolio in Q4 2022.
  • Duquesne Family Office opened 16 new positions and closed 23 in Q4 2022.
  • Duquesne Family Office's portfolio value rose 15% quarter-over-quarter to $2.02B.

Based on Duquesne Family Office's 13F filing for Q4 2022, filed 14 Feb 2023.